Butantan Institute

This study tested a new dengue vaccine called V181 in 1,364 healthy adults aged 18 to 50 in Brazil. The goal was to see if V181 is safe and triggers a strong immune response against all four types of dengue virus, comparing it to an existing vaccine. Results showed that V181 work…

This study tested a new quadrivalent (four-strain) flu vaccine made by Instituto Butantan in over 1,300 healthy infants and children aged 6 to 35 months. The goal was to see if the vaccine triggers a strong immune response and is safe compared to existing flu vaccines. Results wi…